Previous 10 | Next 10 |
home / stock / myndf / myndf news
Vancouver, British Columbia--(Newsfile Corp. - March 1, 2023) - MYND Life Sciences Inc. (CSE: MYND) ("MYND" or the "Company") announces that it has been advised by its external auditors (the "Auditors") that they will not be in a position to complete their work on the Company's annual consolida...
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2023) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ( " MYND " or the " Company "), a biopharmaceutical research and development company creating innovated and precision medicines for patients with relentless neurological disea...
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) (" Mynd " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentl...
Vancouver, British Columbia--(Newsfile Corp. - June 29, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) (" Mynd " or the " Company ") announces that it has terminated the non-binding memorandum of understanding (" MOU ") to acquire all the issued and outstanding shares of Tid...
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) (" Mynd " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients wit...
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) (" Mynd " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with...
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2022) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), is pleased to announce that it plans to undertake a non-brokered private placement offering (the " Offering ") of common shares in sh...
MYND Life Sciences (OTCPK:MYNDF) entered into a non-binding memorandum of understanding to acquire all the issued and outstanding shares of Tidal Care (Tidal Psychedelics). Tidal — which has access to a $10M leasehold facility built for cannabis and mycelium cultivation ...
MYND expresses the intention to acquire all the issued and outstanding shares of Tidal Psychedelics Vancouver, British Columbia--(Newsfile Corp. - March 16, 2022) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), a biopharmaceutical research and developme...
Vancouver, British Columbia--(Newsfile Corp. - March 9, 2022) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("MYND" or "the Company") announces the hiring of a Senior Operations and Research Manager and the resignation of a company officer. MYND is pleased to announce the...
News, Short Squeeze, Breakout and More Instantly...
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company ") The Company is pleased to welcome Ms. Laurie Bakke who was recently appointed to MYND's Board. Ms. Bakke joins as an independent non-executive director,...
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), a pioneering biopharmaceutical research and development company committed to advancing treatments for patients coping with chronic and a...
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), We are delighted to announce the appointment of Mynd Life Sciences current CEO and Director, the Hon. Dr. Lyle Oberg, E.C.A., as the Boa...